Rational-Combination-of-CRM1-Inhibitor-Selinexor-and-Olaparib-Shows-Synergy-in-Ovarian-Cancer-Cell-Lines-and-Mouse-Models
Published in Molecular Cancer Therapeutics, 2021
Recommended citation: Katelyn Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar, Santosh Dasari, Nghi Nguyen, Reid Powell, Mary Sobieski, Cristina Ivan, Mark Kim, Sujanitha Umamaheswaran, Deanna Glassman, Yunfei Wen, Paola Amero, Clifford Stephan, Robert Coleman, Yosef Landesman, Shannon Westin, Prahlad Ram, Anil Sood. "Rational-Combination-of-CRM1-Inhibitor-Selinexor-and-Olaparib-Shows-Synergy-in-Ovarian-Cancer-Cell-Lines-and-Mouse-Models." Molecular Cancer Therapeutics, 2021.
Download Paper